Catalyst Biosciences, Inc. - Special Call Transcript
Greetings, and welcome to the Catalyst Biosciences ISTH Data Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to Catalyst Biosciences. Thank you. You may begin.
Thank you, and welcome to the investor update call following the data presentations at the ISTH meeting. Joining me are Dr. Nassim Usman, President and Chief Executive Officer; Dr. Howard Levy, Chief Medical Officer; Fletcher Payne, Chief Financial Officer; and Dr. Grant Blouse, Vice President Translational Research.
Before we begin, I would like to remind you that various remarks that we make on this call contain forward-looking statements, including statements regarding expected regulatory and clinical actions and developments and projected operating expenses. These statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied in the statements themselves.
All forward-looking statements made on this call
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |